ENZYVANT SCIENCES
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
ENZYVANT SCIENCES
Industry:
Biopharma Biotechnology Health Care Medical
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.enzyvant.com
Total Employee:
11+
Status:
Active
Contact:
+41612254202
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Similar Organizations
ApaTech
ApaTech is an orthobiologics company producing synthetic bone repair materials.
Autolomous
Autolomous is an biotechnology company engaged in manufacturing pragmatic digital solutions for cell and gene therapy.
Biomeb
Biomeb is a biotechnology company that provide personalized medicine for prevention, diagnosis and treatment of different pathologies.
CELLnLIFE
CELLnLIFE develops stem cell therapy for the treatment of rare and intractable diseases.
Certis USA
Certis USA is a biotechnology company specializing in biological product development solutions.
ERS Genomics
ERS Genomics is a biotechnology company to provide broad access to the foundational CRISPR-Cas9 intellectual property.
Genea
Genea provides assisted reproductive technology products and services alongside its subsidiaries.
GlycoMar
GlycoMar is a biotechnology company developing products for the human healthcare and personal care markets.
GPC Biotech
GPC Biotech is a German biopharmaceutical company that discovers and develops anticancer drugs.
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
Igen Biotech
Igen Biotech is a biotechnological company that translates biomedical research into practical and marketable medical devices and services.
Inatherys
Inatherys is a biotechnology company developping monoclonal antibodies for the treatment of cancers and inflammatory diseases.
LifeArc
LifeArc is an independent life science medical research charity committed to drastically improving positive patient outcomes everywhere.
NeoDynamics
This company is a Swedish medical technology company focused on improving the diagnosis and treatment of breast cancer.
Neurotec Pharma
Neurotec Pharma is focused on developing new treatments for acute and chronic central nervous system (CNS) diseases.
OROX BioSciences
OROX BioSciences is a biotechnology start-up focused on the rapid discovery and development of novel small molecule medications.
OXOlife
Oxolife is a biotechnology company in the clinical phase of development.
Oxxon Therapeutics
Oxxon Pharmaccines Ltd., an Oxford, UK-based biotech company focused on immunotherapies.
Pharmaceutical Biotechnology
Pharmaceutical Biotechnology focuses on the development and implementation of new biotech projects with high market potential.
Procella Therapeutics
Procella Therapeutics is an early stage biotechnology company focused on developing cardiac stem cell technology.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Protomer Technologies
Protomer Technologies is a biotechnology company that focuses on metabolic diseases.
R&D Systems
R&D Systems is a product and services agency bringing together resources for Cell Biology research.
Radiopharma
Radiopharma engages in nuclear medicine and molecular imaging for the diagnosis and treatment of several diseases.
Retina Implant
Retina Implant is a biotech company which develops subretinal implants for partially sighted and blind patients.
Stemmatters
Stemmatters is a biotechnology company focused on regenerative medicine.
Wellcome Trust
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health.
Xenova
Xenova publicly quoted biotechnology company focused on the development of novel drugs to treat cancer and addiction.
Current Employees Featured
Judy Chuk VP of Strategy and Operations @ Enzyvant Sciences
VP of Strategy and Operations
2017-02-01
Johanna Rossell Chief Commercial Officer @ Enzyvant Sciences
Chief Commercial Officer
2022-01-01
Bill Symonds CEO @ Enzyvant Sciences
CEO
2022-03-01
Official Site Inspections
http://www.enzyvant.com Semrush global rank: 5.51 M Semrush visits lastest month: 1.55 K
- Host name: ec2-44-196-228-95.compute-1.amazonaws.com
- IP address: 44.196.228.95
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Enzyvant Sciences"
Enzyvant Sciences - Crunchbase Company Profile
Organization. Enzyvant Sciences . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare …See details»
Enzyvant - LinkedIn
Enzyvant is now Sumitomo Pharma America (SMPA), a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in …See details»
Enzyvant Announces Merger with Altavant - GlobeNewswire
Dec 6, 2022 A nimble and unique organization, Enzyvant has a full range of capabilities spanning non-clinical and clinical development and commercialization and is developing in …See details»
Enzyvant Announces Merger with Altavant - Yahoo Finance
Dec 6, 2022 Combined company has full range of capabilities required to advance bold science for rare diseases in immunology and cardiopulmonologyCARY, N.C., Dec. 06, 2022 (GLOBE …See details»
Enzyvant Company Profile | Management and Employees List
Enzyvant's lead asset is the investigational tissue-based regenerative therapy, RVT-802, for congenital athymia, an ultra-rare and life-threa tening pediatric immunodeficiency. RVT-802 …See details»
Enzyvant - Overview, News & Similar companies | ZoomInfo.com
Jan 22, 2023 Who is Enzyvant. Enzyvant, a wholly owned subsidiary of Sumitovant Biopharma Ltd. (wholly owned by Sumitomo Dainippon Pharma Co., Ltd.), is a biotechnology company …See details»
Enzyvant Company Profile - Office Locations, Competitors ... - Craft
Enzyvant is a company developing transformative therapies for people with rare diseases. Its pipeline includes investigational regenerative medicine therapies for T cell–implicated …See details»
Enzyvant Stages NC HQ for Rare-Disease Battles
Dec 5, 2022 Enzyvant Therapeutics, Inc. and Altavant Sciences, Inc., both wholly owned subsidiaries of the global biopharmaceutical giant Sumitovant Biopharma Ltd., today …See details»
Enzyvant Announces Merger With Altavant - Drug Development …
A nimble and unique organization, Enzyvant has a full range of capabilities spanning non-clinical and clinical development and commercialization and is developing in-house manufacturing. …See details»
Enzyvant - Products, Competitors, Financials, Employees, …
A nimble and unique organization, Enzyvant has a full range of capabilities spanning non-clinical and clinical development and commercialization and is developing in-house manufacturing. …See details»
Enzyvant Company Profile 2024: Valuation, Investors ... - PitchBook
Enzyvant General Information Description. Operator of a biopharmaceutical firm intended for the treatment of patients with farber disease. The company is focused on the development of …See details»
Inside The Altavant/Enzyvant Self-Made Merger - Bioprocess Online
Dec 21, 2022 Enzyvant’s allogeneic processed thymus tissue–agdc, RETHYMIC, was approved for the treatment of congenital athymia in pediatric patients in 2021. ... its lead candidate,” …See details»
Enzyvant Sciences - VentureRadar
"Enzyvant is a biotechnology company focused on developing transformative therapies for patients with rare diseases. The FDA has accepted Enzyvant’s Biologics License Application …See details»
Press Release Distribution and Management - GlobeNewswire
Apr 27, 2021 Enzyvant Receives 2022 Rare Impact Industry Innovation Award from the National Organization for Rare Disorders (NORD) for Novel, Tissue-Based Therapy to Treat Ultra-Rare, …See details»
Enzyvant Announces Merger with Altavant - BioSpace
Dec 6, 2022 A nimble and unique organization, Enzyvant has a full range of capabilities spanning non-clinical and clinical development and commercialization and is developing in …See details»
Enzyvant Announces Merger with Altavant - DistilINFO LifeSciences
Dec 12, 2022 A nimble and unique organization, Enzyvant has a full range of capabilities spanning non-clinical and clinical development and commercialization and is developing in …See details»
Enzyvant - Biotech Careers
Enzyvant is an accelerator for transformative regenerative medicines with a focus on tissue-based therapies for rare conditions. Their flagship FDA-approved product, Rethymic, is allogeneic …See details»
Enzyvant Receives 2022 Rare Impact Industry Innovation
Jun 27, 2022 Enzyvant Receives 2022 Rare Impact Industry Innovation Award from the National Organization for Rare Disorders (NORD) for Novel, Tissue-Based Therapy to Treat Ultra-Rare, …See details»
Enzyvant Company Overview, Contact Details & Competitors
Rare Disease Focus Enzyvant specializes in rare diseases, offering life-altering solutions for small communities with significant unmet medical needs. This unique focus presents a sales …See details»
Enzyvant gains double fast-track for rare disease drug
3 days ago Enzyvant says it expected a potential BLA filing in the first half of 2018. However the cutting-edge nature of the drug and techniques involved means that RVT-801 will be a pioneer …See details»